Raymond James Financial Inc Novavax Inc Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Novavax Inc stock. As of the latest transaction made, Raymond James Financial Inc holds 67,644 shares of NVAX stock, worth $549,945. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,644Holding current value
$549,945% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVAX
# of Institutions
285Shares Held
94.7MCall Options Held
6.95MPut Options Held
9.4M-
Vanguard Group Inc Valley Forge, PA15.4MShares$125 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$96.3 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$90.6 Million35.54% of portfolio
-
State Street Corp Boston, MA7.69MShares$62.5 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.94MShares$48.3 Million0.07% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $636M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...